Treating Blood Cancers

By Blood Cancer United

Podcast Series for Professionals by Blood Cancer United... more

4.8

1212 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 145 episodes available.

Treating Blood Cancers episodes:

January 23, 2026Building Resilience: Burnout & Compassion Fatigue Tools for HCPs
Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT
Recorded on January 8, 2026

Chelsey Winegar, LCSW, MBA
Manager of Oncology Services
Intermountain Health
Murray, UT
Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences between burnout and compassion fatigue, and why understanding both is essential for the well being of healthcare professionals and the patients they serve.
Chelsey shares practical strategies for recognizing early warning signs, monitoring staff wellness, and building supportive, stigma free environments. The episode also highlights resources and education to help clinicians maintain resilience in demanding clinical settings. Listen in to learn more today!
Mentioned on this episode:
Trauma Stewardship
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
...more
37min
January 13, 2026Key Insights from Attending ASH 2025
Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC
Recorded on December 18, 2025

Lore Gruenbaum, PhD
Chief Scientific Officer & Senior Vice President of Research
Blood Cancer United
Washington, DC
Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the Blood Cancer United Beat AML® Master Clinical Trial as a model for AI-driven trial design and real-time clinical decision-making. Tune in today for the key takeaways you need to know!
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
...more
34min
December 17, 2025Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
Raymond Mailhot, MD, MPH, University of Miami, Miami, FL
Recorded on December 2, 2025

Raymond Mailhot, MD, MPH
Department of Radiation Oncology
University of Miami
Miami, FL
Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes!
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Medical Debt Case Management Program for Patients
Blood Cancer United Additional Resources for Patients
...more
31min
November 20, 2025 Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
Paul J. Hampel, MD, Mayo Clinic, Rochester, MN
Recorded on November 4, 2025

Paul J. Hampel, MD
Assistant Professor of Medicine
Division of Hematology, Department of Medicine
Mayo Clinic
Rochester, MN
In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.
...more
41min
November 06, 2025 Managing CML: What HCPs Need to Know
Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on October 23, 2025

Michael J. Mauro, MD
Director, Chronic Myeloid Leukemia Program
Professor of Medicine, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY
Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy selection, and best practices for managing treatment-related side effects. He also shares updates on TKI discontinuation criteria, long-term monitoring, and a forward look at ongoing trials and emerging therapeutic advances shaping the future of CML care. Gain actionable insights to enhance patient outcomes today!
...more
38min
October 10, 2025 Understanding MRD: Insights for clinical practice and patient care
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA
Recorded on September 25, 2025

Rahul Banerjee, MD, FACP
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA
In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice!
This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
...more
33min
September 19, 2025 Pediatric Acute Leukemias: Focus on clinical trials for treatment
Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Recorded on September 9, 2025

Ann Collins, PA
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC
Kelly Laschinger, MSN, RN, CPNP, CPHON
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC
Sarah K. Tasian, MD
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of Pennsylvania School of Medicine
Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia
Philadelphia, PA
Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today!
...more
39min
July 09, 2025 Charting the Course of ALL: From Diagnosis to Advances
Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA
Recorded on June 27, 2025

Catherine Lai, MD, MPH
Associate Professor
Physician Leader, Leukemia Clinical Research Unit
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA
In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for Advanced Medicine, joins us to discuss the current landscape of adult acute lymphoblastic leukemia (ALL) treatment. She highlights recent advances in frontline and relapsed therapies, the critical role of measurable residual disease (MRD), and the use of immunotherapy and targeted treatments. Dr. Lai further explores transplant considerations, management of side effects, and tailored approaches for B-cell and T-cell ALL. She also emphasizes patient-centered care, including strategies for end-of-life discussions and shared decision-making. Tune in today for expert insights and practical takeaways on the evolving future of ALL care!
...more
37min
June 12, 2025 Strategies and Advances in AML
Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH
Recorded on May 27, 2025

Uma Borate, MBBS, MS
Associate Professor, Division of Hematology
Acute Leukemia Clinical Research Disease Group Leader
The Ohio State University
Columbus, OH
What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, Ohio, as she dives into emerging breakthroughs in AML biology, including molecular drivers, menin inhibitors, and the challenges of developing bispecifics and CAR T-cell therapies. She also shares updates from the LLS Beat AML® Master Clinical Trial and ongoing clinical trials, and reflects on the evolving treatment landscape across age groups. Don’t miss this dynamic conversation packed with expertise and hope for the future of AML!
...more
39min
May 29, 2025 Advancing Care in Myeloproliferative Neoplasms (MPNs)
Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH
Recorded on May 13, 2025

Aaron Gerds, MD, MS
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University School of Medicine
Medical Director
Case Comprehensive Cancer Center Clinical Research Office
Cleveland, OH
In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs!
This episode is supported by GSK plc and Karyopharm Therapeutics.
...more
33min

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 145 episodes available.

More shows like Treating Blood Cancers

Marketplace by Marketplace

Marketplace

8,796 Listeners

The Daily by The New York Times

The Daily

113,393 Listeners

Today, Explained by Vox

Today, Explained

10,306 Listeners

VJHemOnc Podcast by VJHemOnc

VJHemOnc Podcast

2 Listeners

The Blood Cancer Experience by LLSC

The Blood Cancer Experience

0 Listeners